News
![AbbVie's Rick Gonzalez](/sites/default/files/styles/x_large/public/2023-12/rick_gonzalez_headshot_960-540.jpg?itok=QfSEdJ3M)
AbbVie swoops on Pfizer spin-out Cerevel with $8.7bn offer
AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics, w